NCT06378866 2026-04-20
DIVINE
Mayo Clinic
Phase 2 Recruiting
Clinical Trials
12 trialsNCT06378346 2026-02-23
GU-01
University of Illinois at Chicago
Phase 2 Recruiting
NCT06733350 2026-02-09
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Phase 4 Suspended
NCT04519879 2025-10-29
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
City of Hope Medical Center
Phase 2 Active not recruiting
NCT06200103 2025-09-11
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Mayo Clinic
Phase 2 Recruiting
NCT06292897 2024-03-05
OBESITA'&PCa
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Recruiting
NCT04024475 2022-06-08
Prostate Cancer Biobank
Swiss Cancer Institute
Active not recruiting
NCT02614859 2022-03-29
BIMET-1
Fox Chase Cancer Center
Phase 2 Completed
NCT03896178 2021-03-01
Prostate Cancer in Firemen: Early Diagnosis Because of Increased Diagnostic Pressure?
Oslo University Hospital
Completed
NCT03893123 2020-03-04
Prostate Cancer Risk in Firefighters
Oslo University Hospital
Unknown
NCT00169676 2016-06-29
Registry and Database Lap Prostatectomy
Indiana Kidney Stone Institute
Completed
NCT00118066 2015-05-27
Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia
Rutgers, The State University of New Jersey
Phase 2 Terminated